Preclinical and Clinical study of siddha drugs Kukkil Chooranam (Internal) and Thuvara Ennai (External) in the Treatment of Pun (Naalavibatha Pun-Varicose Ulcer)

The disease Naalavibatha pun was taken for the clinical study with Kukkil Chooranam as internal medicine and Thuvaraennai as external application. For the clinical study, 40 cases were selected based on the approved protocol. This study has been approved by IEC of NIS [Date of IEC Approval& its number: NIS/IEC/9-2014-15/14-26.08.2015]. Animal studies were carried out after obtaining approval from the Institutional Animal Ethical Committee (IAEC) and the trial was registered in Clinical Trial Registry of India (CTRI/2017/05/008584). Hence the study is safely executed on patients and there was no adverse drug reactions noted during the study period. The toxicological evaluations were conducted as per WHO guidelines for safety evaluation of Kukkil Chooranam. In long term toxicity study, no signs of toxicity and mortality were observed throughout the study period up to the dose of 2000mg/kg body weight. Thus, the LD50 value of Kukkil Chooranam was found to be greater than 2000mg/kg body weight. In Long term toxicity study, there were no significant changes in behavioral signs, food intake, water intake, Lipid Profile, Renal parameters hematological parameters, and Hepatic parameters. The liver function test conducted at the end of the study, test groups (Low, Mid, High dose) revealed no significant changes in level of liver parameters, when compared with control group animals. In organs of Control group, no abnormality was detected. The normal histological structure present in test group of animals. Out of the 40 cases, 10 cases were treated in IPD and remaining 30 cases were treated in OPD of Ayothidoss Pandithar Hospital of National Institute of Siddha, Chennai-47. The detailed study on Naalavibatha pun with reference to its aetiology, pathogenesis, investigations, clinical features, diagnosis and treatment with trial drugs were done. The results were observed by VCSS score. Among the 40 cases treated, 62.5% cases had shown Good improvement, 20% cases had shown Moderate improvement and 17.5% had shown Mild improvement. CONCLUSION: The present clinical study confirms the efficacy of the trial drugs Kukkil chooranam (Internally) and Thuvara Ennai (Externally). It was found to be good resulting on Naalavibatha pun patients in reducing clinical symptoms like ulcer, itching, oozing, pain and oedema. The Short term and Long term toxicitystudiesdid not show any toxic effects in the animal. The quantitative outcome of VCSS score shows there is significant reduction between before and after treatment. The qualitative outcome shows there is 62.5% of cases had shown good improvement, 20% of cases had shown moderate improvement and remaining 17.5% of cases had shown mild improvement. The clinical trial conducted in selected patients was satisfactory and the results were encouraging. However a study with large number of patients is required to fine out the ideal dose response. The cost of the trail medicines are Low. These drugs are easily available and the dosage is also convenient. These drugs may be taken up for further exploratory randomised clinical trials to confirm the efficacy

Transition metal titanium (Ti) doped LaFeO3 nanoparticles for enhanced optical structural and magnetic properties

A series of LaFe1−xTixO3 (x = 0.0, 0.2, 0.4, 0.6 and 0.8) nanoparticles have been successfully synthesized by simple co-precipitation technique. The synthesized samples (calcined at 800° C/3hr) were characterised for structural, optical and magnetic properties. Structural phase formation of the crystal shows orthorhombic planes of these samples phases. The average crystallite size (Dc) is decreasing with a dopant and found to be varying between ∼ 9 and 25 nm. Tailored surface morphology was analyzed using scanning electron microscope (FESEM) and transmission electron microscopes (TEM) with selected area electron diffraction pattern (SAED) also confirms the evolution of orthorhombic phases. Diffuse reflectance spectra (DRS) are recorded to evaluate the variation of optical band gap (Eg) upon titanium doping into the LaFeO3 system. The obtained results attributed that Eg values are increasing with dopant altering between 2.05 and 2.61 eV. The metal oxide (M - O) stretching vibrations and few functional groups are detected from infrared spectra (IR). The weak ferromagnetic behaviour is observed from hysteresis loop behaviour. Additionally, the large hysteresis loop behaviour induces no saturation up to 15 kOe in nanoparticles coercivity (Hc) and anisotropy constants (K1) are eventually decreasing with ‘x’ values

Rhodobacter johrii sp. nov., an endospore-producing cryptic species isolated from semi-arid tropical soils

An oval to rod shaped phototrophic purple nonsulfur bacterium, strain JA192T was isolated from an enrichment culture of a pasteurized rhizosphere soil sample of jowar crop collected from Godumakunta village, near Hyderabad, India. Strain JA192T is Gram-negative, motile and produces endospores. Phylogenetic analysis on the basis of 16S rRNA gene sequences showed that the strain JA192T is closely related to Rhodobacter sphaeroides DSM 158T (99.9% sequence similarity), Rhodobacter megalophilus JA194T (99.8%) and Rhodobacter azotoformans JCM 9340T (98.1%) and clusters with other species of the genus Rhodobacter of the family Rhodobacteraceae. However, DNA-DNA hybridization with Rba. sphaeroides DSM 158T, Rba. megalophilus JA194T and Rba. azotoformans JCM 9320T showed a relatedness of only 38-57% with respect to JA192T. On the basis of 16S rRNA gene sequence analysis, DNA-DNA hybridization data, morphological, physiological and chemotaxanomic characters, strain JA192T represents a novel species of the genus Rhodobacter, for which the name Rhodobacter johrii sp. nov. is proposed. The type strain is JA192T (= DSM 18678T = JCM 14543T = MTCC 8172T)

<em>Marichromatium indicum</em> sp. nov., a new purple sulfur Gammaproteobacterium from mangroves of Goa, India

A reddish-brown bacterium was isolated from photoheterotrophic enrichments of mangrove soil from the western coast of India, in a medium that contained 10 % (w/v) NaCl. Phylogenetic analysis on the basis of 16S rRNA gene sequences showed that strain JA100T clusters with species of the genus Marichromatium of the class ‘Gammaproteobacteria’. Cells of strain JA100T are Gram-negative, motile rods with monopolar single flagella; they require NaCl, the optimum concentration being 1–4 %, and tolerate concentrations up to 13 %. The strain has vesicular internal membrane structures, bacteriochlorophyll a and, most probably, carotenoids of the spirilloxanthin series. No growth factors are required. A reduced sulfur source is required for growth, and, during growth on reduced sulfur sources as electron donors, sulfur is intermediately deposited as a single large granule within the cell. Strain JA100T could not grow at the expense of other tricarboxylic acid cycle intermediates, except malate. On the basis of 16S rRNA gene sequence analysis and its morphological and physiological characteristics, strain JA100T is sufficiently different from other Marichromatium species to justify its designation as a novel species, for which the name Marichromatium indicum sp. nov. is proposed. The type strain is JA100T (=DSM 15907T=ATCC BAA-741T=JCM 12653T)

Photocatalytic hydrogen generation from water using a hybrid of graphene nanoplatelets and self doped TiO2-Pd

Nanohybrids of self doped (Ti doped or reduced TiO -TiOR) TiO-graphene nanoplatelets (TiO R-G) of different compositions are synthesized by a facile soft chemical method. A decrease of bandgap and improved visible light absorption is exhibited by TiOR-G. Based on current-voltage (I-V) measurements, it is concluded that the hybrid material possesses improved electron transport properties compared to TiOR and pure TiO. A detailed characterization of the composites indicated that TiOR exists as a dispersed phase on graphene nanoplatelets (graphene). Among different compositions of the composites, the catalyst containing 3 weight% of graphene (TiOR-3G) shows enhanced photocatalytic activity for hydrogen generation from water compared to both TiO and TiOR. When Pd is used as co-catalyst in this composite, a large increase in the activity is observed. The increased efficiency of the nanocomposite is attributed to factors like: (i) improved visible light absorption promoted by G and Ti dopant (ii) increased lifetime of the charge carriers assisted by the enhanced electron transporting properties of G (iii) increased number of active sites for hydrogen evolution provided by the Pd co-catalyst. This work highlights the role of TiO based hybrid materials as efficient photocatalysts for solar energy utilization. This journal i

In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore

OBJECTIVE: Carbapenem-resistant Acinetobacter baumannii (CR-AB) is an emerging cause of nosocomial infections worldwide. Combination therapy may be the only viable option until new antibiotics become available. The objective of this study is to identify potential antimicrobial combinations against CR-AB isolated from our local hospitals. METHODS: AB isolates from all public hospitals in Singapore were systematically collected between 2006 and 2007. MICs were determined according to CLSI guidelines. All CR-AB isolates were genotyped using a PCR-based method. Clonal relationship was elucidated. Time-kill studies (TKS) were conducted with polymyxin B, rifampicin and tigecycline alone and in combination using clinically relevant (achievable) unbound concentrations. RESULTS: 31 CR AB isolates were identified. They are multidrug-resistant, but are susceptible to polymyxin B. From clonal typing, 8 clonal groups were identified and 11 isolates exhibited clonal diversity. In single TKS, polymyxin B, rifampicin and tigecycline alone did not exhibit bactericidal activity at 24 hours. In combination TKS, polymyxin plus rifampicin, polymyxin B plus tigecycline and tigecycline plus rifampicin exhibited bactericidal killing in 13/31, 9/31 and 7/31 isolates respectively at 24 hours. Within a clonal group, there may be no consensus with the types of antibiotics combinations that could still kill effectively. CONCLUSION: Monotherapy with polymyxin B may not be adequate against polymyxin B susceptible AB isolates. These findings demonstrate that in-vitro synergy of antibiotic combinations in CR AB may be strain dependant. It may guide us in choosing a pre-emptive therapy for CR AB infections and warrants further investigations